Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q3 FY26 results · Oct–Dec 2025
Medplus Health Services reported revenue from operations of ₹1,806.12 crore (up 15.7% from Q3 FY25) and net profit of ₹57.79 crore (up 26.0% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,806.12 | 1,561.45 | +15.7% | 1,679.33 | +7.5% |
| Other income | 18.24 | 12.52 | +45.7% | 17.47 | +4.4% |
| Total income | 1,824.36 | 1,573.96 | +15.9% | 1,696.80 | +7.5% |
| Profit before tax | 73.29 | 56.60 | +29.5% | 68.94 | +6.3% |
| Net profit for the period | 57.79 | 45.87 | +26.0% | 55.50 | +4.1% |
| Attributable to shareholders of the company | 57.81 | 45.89 | +26.0% | 55.50 | +4.2% |
| EPS, basic (₹) | 4.82 | 3.84 | +25.5% | 4.63 | +4.1% |
| Net margin (%) | 3.2 | 2.9 | 3.3 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 223.00 | 176.79 | +26.1% | 205.65 | +8.4% |
| Other income | 2.70 | 2.19 | +23.2% | 2.94 | −8.2% |
| Total income | 225.70 | 178.98 | +26.1% | 208.59 | +8.2% |
| Profit before tax | 21.83 | 12.03 | +81.4% | 20.61 | +5.9% |
| Net profit for the period | 16.58 | 9.37 | +76.9% | 15.63 | +6.0% |
| EPS, basic (₹) | 1.38 | 0.78 | +76.9% | 1.31 | +5.3% |
| Net margin (%) | 7.4 | 5.3 | 7.6 |
Consolidated
- Filed with BSE
- 30 Jan 2026, 18:47 IST
- Board meeting
- 30 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 Jan 2026, 18:47 IST
- Board meeting
- 30 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE